RxDoctor Payments Data

Mark Hagy, MD

Foot and Ankle Surgery · Salem, VANPI 1235171406

Payments from drug & device makers

$2,590in general payments, 2019–2025

Across 48 payments — averaging $53.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sioux Surgical Inc$991
  • Stryker$610
  • Johnson & Johnson$222
  • Arthrex$154
  • Zimmer Biomet$115
  • Organogenesis Inc.$64
  • plus $434 from 12 others

What the payments were for

  • Food & beverage$1,47057%
  • Education$1,12043%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sioux Surgical Inc1$991
Stryker16$610
Johnson & Johnson(2 entities)6$222
Arthrex1$154
Zimmer Biomet1$115
Organogenesis Inc.1$64
Amgen4$61
Pacira Pharmaceuticals Incorporated2$52
Hydrofera LLC2$48
RSW Medical Company, Inc.2$46
Paragon 28, Inc.1$45
Lilly USA, LLC2$34
Exact Sciences2$33
Vertex2$33
Novo Nordisk2$27
Vericel Corporation1$24
Pfizer1$16
E.r. Squibb & Sons, L.L.C.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,590 in reported general payments places this provider in the 40th percentile of 260 foot and ankle surgery providers in Virginia.

See all foot and ankle surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$150,551
Medicare patients
426
Services billed
1,841

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib31$509
Meloxicam56$175

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Salem

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →